SLG
Stanley-Laman Group Portfolio holdings
AUM
$673M
1-Year Return
14.64%
This Quarter Return
+8.13%
1 Year Return
+14.64%
3 Year Return
+60.49%
5 Year Return
+79.33%
10 Year Return
+186.95%
AUM
$453M
AUM Growth
+$37.4M
(+9%)
Cap. Flow
+$5.06M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
22.62%
Holding
270
New
36
Increased
124
Reduced
34
Closed
42
Top Buys
| 1 |
S&P Global
SPGI
|
$6.32M |
| 2 |
Fortinet
FTNT
|
$5.58M |
| 3 |
MSCI
MSCI
|
$5.54M |
| 4 |
Moody's
MCO
|
$5.52M |
| 5 |
Mondelez International
MDLZ
|
$2.63M |
Top Sells
| 1 |
Danaher
DHR
|
$6.72M |
| 2 |
Tyler Technologies
TYL
|
$6.47M |
| 3 |
TIF
Tiffany & Co.
TIF
|
$6.1M |
| 4 |
Palo Alto Networks
PANW
|
$4.91M |
| 5 |
Akebia Therapeutics
AKBA
|
$4.3M |
Sector Composition
| 1 | Technology | 29.27% |
| 2 | Healthcare | 16.12% |
| 3 | Financials | 10.88% |
| 4 | Industrials | 10.21% |
| 5 | Communication Services | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Agilysys
AGYS
$3.1B
| $772K | 0.17% |
31,943
+2,316
| +8% | +$56K |
|
127
Sherwin-Williams
SHW
$92.9B
| $769K | 0.17% |
+3,312
| New | +$769K |
|
|
MNTV
128
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $765K | 0.17% |
34,621
+6,667
| +24% | +$147K |
|
129
RBC Bearings
RBC
$12.2B
| $736K | 0.16% |
6,074
+246
| +4% | +$29.8K |
|
130
Accenture
ACN
$159B
| $694K | 0.15% |
3,070
+69
| +2% | +$15.6K |
|
131
CRA International
CRAI
$1.28B
| $672K | 0.15% |
17,941
+430
| +2% | +$16.1K |
|
132
Thermo Fisher Scientific
TMO
$186B
| $561K | 0.12% |
1,270
+109
| +9% | +$48.1K |
|
133
Abbott
ABT
$231B
| $554K | 0.12% |
5,089
-405
| -7% | -$44.1K |
|
|
EGRX
134
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $510K | 0.11% |
12,000
-12,000
| -50% | -$510K |
|
135
General Dynamics
GD
$86.8B
| $501K | 0.11% |
3,616
-402
| -10% | -$55.7K |
|
|
EBSB
136
DELISTED
Meridian Bancorp, Inc.
EBSB
| $454K | 0.1% |
+28,130
| New | +$454K |
|
137
Zoetis
ZTS
$67.9B
| $446K | 0.1% |
2,700
+76
| +3% | +$12.6K |
|
138
West Pharmaceutical
WST
$18B
| $441K | 0.1% |
1,605
| – | – |
|
139
Synopsys
SNPS
$111B
| $436K | 0.1% |
2,038
+11
| +0.5% | +$2.35K |
|
140
Agilent Technologies
A
$36.5B
| $424K | 0.09% |
4,205
+118
| +3% | +$11.9K |
|
141
Intuitive Surgical
ISRG
$167B
| $424K | 0.09% |
1,794
+57
| +3% | +$13.5K |
|
142
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $411K | 0.09% |
11,080
-7,230
| -39% | -$268K |
|
143
Mastercard
MA
$528B
| $405K | 0.09% |
1,199
-18
| -1% | -$6.08K |
|
144
Visa
V
$666B
| $403K | 0.09% |
2,014
+198
| +11% | +$39.6K |
|
145
Intuit
INTU
$188B
| $361K | 0.08% |
1,107
+37
| +3% | +$12.1K |
|
146
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $355K | 0.08% |
8,672
-5,852
| -40% | -$240K |
|
147
Morningstar
MORN
$10.8B
| $350K | 0.08% |
2,180
+88
| +4% | +$14.1K |
|
148
Pool Corp
POOL
$12.4B
| $328K | 0.07% |
+980
| New | +$328K |
|
149
Vertex Pharmaceuticals
VRTX
$102B
| $328K | 0.07% |
+1,204
| New | +$328K |
|
150
Intercontinental Exchange
ICE
$99.8B
| $326K | 0.07% |
3,256
-59
| -2% | -$5.91K |
|